BST2 and plasma cell myeloma: As seen in Fig. 1A, many HM samples, including those from Burkitt’s lymphoma [BL], acute myeloid leukemia [AML], and multiple myeloma [MM], had much higher levels of CD317 than their corresponding normal samples.